25th Feb 2026 Long-term outcomes of atacicept therapy in IgA nephropathy patients: a plain language summary
25th Apr 2025 Plain language summary of first-line treatment with amivantamab-lazertinib for high-risk EGFR-positive lung cancer from the MARIPOSA study
